Loading...

The Safety and Efficacy of the Repeated PRRT with [(90)Y]Y/[(177)Lu]Lu-DOTATATE in Patients with NET

PURPOSE: The peptide receptor radionuclide therapy (PRRT) is a treatment option for patients with disseminated, inoperable G1 and G2 neuroendocrine tumours (NETs). The study aims to evaluate the safety, efficacy, and progression-free survival (PFS) of patients after retreatment (R-PRRT) and re-retre...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Endocrinol
Main Authors: Zemczak, Anna, Gut, Paweł, Pawlak, Dariusz, Kołodziej, Maciej, Królicki, Leszek, Kos-Kudła, Beata, Ruchała, Marek, Kamiński, Grzegorz, Kunikowska, Jolanta
Format: Artigo
Sprog:Inglês
Udgivet: Hindawi 2021
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7847334/
https://ncbi.nlm.nih.gov/pubmed/33552155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6615511
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!